The IDSA, HIVMA, and AAHIVM have released a policy paper raising awareness about the implementation of inpatient antiretroviral stewardship programs. In this Q&A, paper coauthor David Koren, PharmD,...
In a session at IAS 2019, Ya-Chi Ho, MD, PhD, MMS, spoke about one of the neglected aspects of HIV treatment. In this Q&A, she answers our questions about this important topic.
Charles Flexner, MD, from Johns Hopkins University answers our questions about aging in HIV, long-acting antiretroviral therapy, and at-risk populations.
Do comorbidities and polypharmacy lead to virologic failure in all populations living with HIV? This was the focus of recent research presented at IDWeek 2018.
A new study of more than 27,000 MSM has indicated that increased HIV PrEP use has unexpectedly led to decreased condom use among men not using PrEP. Consultant360 spoke with lead study author Martin Holt,...
Dr Karin Nielsen from UCLA Mattel Children’s Hospital answers our questions about HIV in infants, mother-to-child transmission, and the future of HIV treatment.
